Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check3 days agoChange DetectedAdded recent entries 136–138 to the Record History, expanding the version history with additional status entries.SummaryDifference0.5%

- Check10 days agoChange DetectedAdded a Compare control and a Study Status field to the Record History page, along with new version entries dated 2026-03-24 to 2026-03-26. This enables easier side-by-side review of changes across versions.SummaryDifference88%

- Check17 days agoChange DetectedAdded Revision: v3.5.0 and streamlined the study history controls by removing several date/version items; this is a UI/history navigation change rather than a modification to the trial data.SummaryDifference16%

- Check24 days agoChange DetectedNew Study Status history entries were added for dates 2026-03-07 through 2026-03-13, extending the version history with status updates.SummaryDifference0.5%

- Check31 days agoChange DetectedNew history entries were added up to 2026-03-06 and the site revision updated to v3.4.3. The previous revision v3.4.2 was removed.SummaryDifference0.6%

- Check38 days agoChange DetectedNew history entries were added for February 2026, documenting updated Study Status revisions (versions 109–113).SummaryDifference0.5%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.